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Abstract We report identification and characterization of
Kv6.3, a novel member of the voltage-gated K+ channel. Reverse
transcriptase-polymerase chain reaction analysis indicated that
Kv6.3 was highly expressed in the brain. Electrophysiological
studies indicated that homomultimeric Kv6.3 did not yield a
functional voltage-gated ion channel. When Kv6.3 and Kv2.1
were co-expressed, the heteromultimeric channels displayed the
decreased rate of deactivation compared to the homomultimeric
Kv2.1 channels. Immunoprecipitation studies indicated that
Kv6.3 bound with Kv2.1 in co-transfected cells. These results
indicate that Kv6.3 is a novel member of the voltage-gated K+
channel which functions as a modulatory subunit. ß 2002 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
Voltage-gated K channels form the largest and most var-
ied family of ion channels (Kv channel family). These chan-
nels play an essential role in controlling cellular excitability in
the nervous system and regulate a variety of neuronal proper-
ties, such as the interspike membrane potential, action poten-
tial waveform and ¢ring frequency [1]. These ¢ndings indicate
the importance of voltage-gated K channels in neuronal sig-
nal transduction and processing. Their contribution to behav-
ior phenotype, such as learning and memory, has also been
studied [2,3].
To date, many members of this Kv channel family have
been identi¢ed and characterized. They have six transmem-
brane domains (TM1^6) and one pore-forming domain, which
is essential for permeation of K, between TM5 and TM6
[4^7]. This secondary structure is evolutionarily conserved.
On the basis of functional characterization of members of
the voltage-gated K channel family, these members have
been divided into two di¡erent subunits, K and Q subunits
[8]. Although these subunits have a similar secondary struc-
ture and sequence similarity, K subunits show voltage-gated
channel activity by themselves, whereas Q subunits do not.
However, when Q subunits are co-expressed with K subunits,
they modify the voltage-gated channel activity which is gen-
erated by K subunits [9^13]. These results demonstrate that
Q subunits function as a modi¢er of K subunits, and this
modi¢cation may express the original activity in living cells.
We attempted to identify a novel member of the Kv channel
family from the human genomic sequencing database. A novel
gene encoding voltage-gated K channel subunits was isolated
which has the most similarity to the Kv6.2 channel and is
mainly expressed in the brain. In this study we report the
molecular cloning, tissue distribution, channel activity, and
binding to the Kv2.1 channel of this gene, Kv6.3. In addition,
the identi¢cation and distribution of a rat ortholog of this
gene are described.
2. Materials and methods
2.1. Molecular cloning of human Kv6.3
The human Kv6.2 amino acid sequence was used for a TBLASTN
search against the human draft genome sequencing database at the
National Center for Biotechnology Information (NCBI). The genomic
clone (GenBank accession number AC025125) was identi¢ed. To iden-
tify the 5P- and 3P-ends of the cDNA corresponding to this fragment,
5P- and 3P-rapid ampli¢cation of cDNA ends (RACE) was performed
using the Human Brain Marathon-Ready cDNA (Clontech, Palo
Alto, CA, USA) and primers derived from the genomic fragment.
Ampli¢ed fragments were directly cloned into the plasmid pCR-
TOPO vector (Invitrogen, Carlsberg, CA, USA) and sequenced on
both strands. The determined sequences were assembled into one con-
tig with an open reading frame encoding 437 amino acids, which is
called human Kv6.3. Finally, to verify that human Kv6.3 cDNA in-
cluding the entire open reading frame could be cloned from an inde-
pendent source, human brain poly(A) RNA (Clontech) was used for
the reverse transcriptase-polymerase chain reaction (RT-PCR). The
RT reaction was primed with random hexamer. The primers for
PCR were 5P-AGGTGTGCGACGACTACGA-3P and 5P-GATGAT-
GACAATGCCACTGC-3P. The ampli¢ed fragment was subcloned
into pCR-TOPO and sequenced on both strands.
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2.2. Molecular cloning and isolation of rat Kv6.3
To isolate a rat homolog cDNA of Kv6.3, a TBLASTN search of
the expressed sequence tag (EST) database of GenBank, using the
human Kv6.3 amino acid sequence, retrieved a rat sequence with
the accession number AI043703 (523 bases). This sequence corre-
sponded to amino acid residues 200^383 of human Kv6.3 and showed
high similarity (93%). To identify the 5P- and 3P-ends of the cDNA
corresponding to the EST, 5P- and 3P-RACE were performed using the
Rat Brain Marathon-Ready cDNA (Clontech) and primers derived
from the EST sequence. The ampli¢ed fragments were directly cloned
into the plasmid pCR-TOPO and sequenced on both strands. The
determined sequences were assembled into one contig with an open
reading frame encoding 345 amino acids. This sequence is externally
similar (95%) to human Kv6.3, indicating that this is the rat counter-
part of Kv6.3.
2.3. RT-PCR analysis
Multiple human and rat poly(A) RNAs (Clontech) were reverse-
transcribed to generate ¢rst-strand cDNAs with Advantage RT-for-
PCR Kit (Clontech). PCR was carried out with these ¢rst-strand
cDNAs, corresponding to 5 ng poly(A) RNA. PCR primers were
designed from the human Kv6.3 cDNA sequence: 5P-TGTCAAG-
AGACCCCTGAA-3P, 5P-TCCATAGCCAACTGTAGTCA-3P and
from the rat Kv6.3 cDNA sequence: 5P-GCATCGTGCGGTTCA-
TCGTC-3P, 5P-CATGTCTCCATAGCCCACTG-3P. PCR was per-
formed for 35 cycles at 98‡C for 15 s and 70‡C for 1 min. The
ampli¢ed fragments were subcloned into pCR-TOPO vector and se-
quenced on both strands to con¢rm the PCR products as human or
rat Kv6.3. As a control, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was ampli¢ed using speci¢c primers (Clontech).
2.4. Electrophysiological studies
Previously isolated cDNA of human Kv6.3 was subcloned into
pcDNA3.1 expression vector (Invitrogen). L929 cells and L929 cells
stably expressing human Kv2.1 were co-transfected with the vector
and green £uorescent protein expression vector using Lipofectamine
(Invitrogen), as described previously [14]. Electrophysiological studies
were carried out 2^4 days after transfection.
Voltage clamp measurements were performed as described previ-
ously [15]. Currents were measured using whole-cell patch-clamp con-
¢gurations with an Axopatch 200B patch-clamp ampli¢er using
pClamp8 software (Axon Instruments). The external solution con-
tained (in mM): KCl 145.4, CaCl2 2, HEPES 10, glucose 15, pH
7.4 with KOH. Patch pipettes (2^5 M6) were ¢lled with the internal
solution containing (in mM): KCl 125, MgCl2 2, CaCl2 1, EGTA 11,
HEPES 10, pH 7.2 with KOH. The activation characteristics of the
Kv channels were determined from tail currents arising from channel
deactivation on repolarizing to 384 mV from step membrane poten-
tials between 364 and +36 mV. The tail current amplitudes were
measured isochronally 5 ms after step pulses and normalized to the
current obtained following a step to +36 mV. These data were ¢t to a
modi¢ed Boltzmann equation:
I tail=Imax  1=1 expV 1=23Vm=k
where Itail is the current amplitude at membrane potential Vm, Imax is
the current amplitude used for normalization, V1=2 is the half-activa-
tion potential, and k is a slope factor [16]. Series resistance was com-
pensated for at least 80%. All recordings were performed at room
temperature (25‡C).
2.5. Immunoprecipitation of Kv6.3 with Kv2.1
Tagged human Kv6.3 and human Kv2.1 were co-transfected into
COS7 cells. 2 days after the transfection the cells were homogenized at
4‡C for 1 h in a solubilizing bu¡er containing 1% Triton X-100,
complete protease inhibitor cocktail (Roche Diagnostics, Mannheim,
Germany) and phosphate-bu¡ered saline (PBS). Insoluble material
was removed by centrifugation at 15 000Ug for 10 min at 4‡C. Mouse
anti-FlagM2 monoclonal antibody (Sigma-Aldrich) was added at 10
Wg/ml for 2 h at 4‡C by addition of protein G immobilized on agarose
beads (Roche Diagnostics) with slow rocking. Pellets were washed
three times in solubilizing bu¡er. The immunoprecipitated proteins
were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (10% polyacrylamide) and transferred onto a nitrocel-
lulose membrane (Hybond-ECL, Amersham Pharmacia Biotech UK,
Buckinghamshire, UK). Blots were saturated with Block Ace (Daini-
hon Seiyaku Co., Osaka, Japan) for 1 h at room temperature and then
incubated for 1 h with primary antibodies: anti-FlagM2 and anti-
Kv2.1 (Upstate Biotechnology, Lake Placid, NY, USA). After several
washes with PBS containing 0.05% Tween 20, the blots were revealed
with puri¢ed goat anti-mouse or anti-rabbit horseradish peroxidase-
conjugated secondary antibodies (1:10 000) (Amersham Pharmacia
Biotech UK) for 1 h at room temperature followed by incubation
with substrate for enhanced chemiluminescence detection (ECL,
Amersham Pharmacia Biotech UK).
3. Results and discussion
3.1. Molecular cloning of a novel putative voltage-gated
K+ channel, Kv6.3
We identi¢ed a genomic clone, AC025750, which encoded a
putative amino acid sequence that was partially similar to
human Kv6.2, by searching the human draft genome sequenc-
ing database. 5P- and 3P-RACE studies using primers designed
from this genomic clone caused an identi¢cation of the full-
length coding sequence (CDS) (1314 bases). This CDS has an
open reading frame encoding 437 amino acids with a pre-
dicted molecular mass of 49 kDa (Fig. 1A). Hydrophilicity
analysis of the amino acid sequence showed that the novel
clone belonged to the K channel family with one pore-form-
ing domain and six transmembrane domains (TM) (Fig. 1B).
Since this novel clone is included in human genomic clone
AC025750, which consists of 176 867 bases and is localized
in chromosome 2 of the human genome, we performed se-
quence alignment with the CDS and AC025750. The align-
ment revealed that the CDS consisted of two exons and one
intron spanning 49 198 bases.
A search of the GenBank database using the BLAST se-
quence alignment program revealed that the full amino acid
sequence of the novel clone showed the closest similarity to
human Kv6.2, which is a member of the voltage-gated K
channel family, and the expected value and identity are
6e313 and 34%, respectively. Alignment of the amino acid se-
Fig. 1. A: Deduced amino acid sequence of hKv6.3. The six puta-
tive transmembrane regions (TM1^6) are underlined. Consensus se-
quences (TxGYG) within the K channels are in boldface. B: Hy-
drophilicity plot of hKv6.3. The six putative transmembrane regions
(TM1^6) and pour region (P) are underlined.
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quence of the novel clone with other voltage-gated K chan-
nels showed low homology: 13.5^19.7%. Also, phylogenetic
analysis suggested that this clone had a common ancestor
with these K channels and represents an additional branch
in the Kv6 subfamily (Fig. 2). These results thus indicated
that this novel clone was a new member of the voltage-gated
K channel, and moreover, was included in the Kv6 subfam-
ily. Therefore, we named this novel clone human Kv6.3
(hKv6.3). Additionally, a rat ortholog of the Kv6.3 gene
(rKv6.3) was identi¢ed from rat brain mRNA, which encodes
345 amino acids with 95.1% identity to hKv6.3.
Fig. 3. Tissue distribution of Kv6.3. A: RT-PCR analysis of
hKv6.3. A, B: Poly(A) RNA (5 ng) from multiple human tissues
and brain regions were reverse-transcribed with a random primer
and ampli¢ed by PCR for hKv6.3. C: Total RNA from primary
cultures of neurons or glial cells from the rat cortex were used for
RT-PCR of rKv6.3. As the positive control of these RT-PCR reac-
tions, GAPDH was ampli¢ed (data not shown).
Fig. 4. Electrophysiological study of hKv6.3. A: Whole-cell macro-
scopic currents elicited in hKv2.1 stably expressed L929 cells and
the cells transfected with hKv6.3. The holding potential was 384
mV, and the cells were depolarized from 364 to +36 mV by 10 mV
increments. B: Voltage-dependent activation curves of hKv2.1 and
hKv2.1/hKv6.3 currents. The normalized tail current amplitude (Itail/
Imax) was ¢t to a modi¢ed Boltzmann equation (see Section 2).
Each data point is the mean þ S.E.M. (n = 7).
Fig. 2. Phylogenetic tree of the human Kv channel family, including
hKv6.3. The tree was generated using the neighbor-joining algo-
rithm of the Phylip program, on the basis of multiple alignment of
conserved sequences of the pore domain analyzed with a Clustal W
program.
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3.2. Tissue distribution of Kv6.3 mRNA
RT-PCR analysis for human multiple mRNA showed that
hKv6.3 mRNA was highly expressed in the brain (Fig. 3A).
Additional analysis revealed that hKv6.3 mRNA was widely
expressed in various regions of the human brain (Fig. 3B).
Since hKv6.3 is expressed in the brain, we veri¢ed whether
Kv6.3 was expressed in neuronal or glial cells of the brain.
RT-PCR analysis with total RNA from neuronal and glial
primary cultured cells from the rat cortex revealed that
rKv6.3 was speci¢cally expressed in neuronal cells (Fig. 3C).
This selective expression is similar to that of Kv2.1, which was
reported to be mainly expressed and function in the brain [17].
3.3. Electrophysiological study of hKv6.3
L929 cells transiently expressing hKv6.3 alone did not yield
functional voltage-gated ion channels (data not shown). How-
ever, co-expression of hKv6.3 and human Kv2.1 (hKv2.1)
gave rise to Kv channels mediating currents distinct from
those of homomultimeric Kv2.1 channels (Fig. 4A). The de-
activation kinetics of the heteromultimeric channels were ob-
viously slower than those of the homomultimeric channels.
Detailed analysis of the tail current amplitude revealed that
the half-maximal activation potential and slope factor of
the heteromultimeric channels (V1=2 =313.3 þ 1.8 mV;
k = 9.8 þ 0.4 mV; mean þ S.E.M.; n = 7) were similar to those
of the homomultimeric channels (V1=2 =313.3 þ 0.8 mV;
k = 9.5 þ 0.2 mV, n = 7) (Fig. 4B).
These ¢ndings are similar to the previously reported pro¢les
of Q subunits. However, they change not only the rates of
deactivation, but also the half-maximal activation potential
of the homomultimeric Kv2.1 channels [9^13]. Thus, Kv6.3
has a novel pro¢le for a Q subunit, which changes only the
rate of deactivation of the K subunits.
3.4. Biochemical association of Kv6.3 with Kv2.1
To test the notion that hKv6.3 and hKv2.1 subunits can
form heteromultimeric channels, we performed an immuno-
precipitation study using cells co-transfected with hKv6.3 and
hKv2.1. Both subunits were expressed in COS7 cells and their
association was shown by co-immunoprecipitation. To allow
the immunoprecipitation of hKv6.3 protein, a ‘FLAG-tag’
sequence was added to the N-terminal of the hKv6.3 coding
sequence. From co-transfected cells, a major band was de-
tected by anti-FLAG or anti-hKv2.1 antibodies. These major
bands with an expected molecular mass correspond to FLAG-
hKv6.3 and hKv2.1 (data not shown). No signal was obtained
from control transfected COS7 cells (data not shown). From
co-transfected cells, hKv6.3 and hKv2.1 were co-precipitated
by anti-FLAG antibodies (anti-‘FLAG-tag’ hKv6.3) (Fig. 5).
These results clearly demonstrate the physical association of
hKv6.3 and hKv2.1 subunits.
3.5. Summary
In this report, we describe the cloning and expression of
Kv6.3, a novel member of the voltage-gated K channel fam-
ily, which was identi¢ed by searching a human genome se-
quencing database. Kv6.3 does not form a functional volt-
age-gated ion channel when expressed by itself, but when
Kv6.3 and Kv2.1 were co-expressed, the heteromultimeric
channels display a decreased rate of deactivation compared
to that of the homomultimeric Kv2.1 channels. These pro¢les
suggested that Kv6.3 is a Q-subunit which does not form func-
tional channels on its own but modulates the properties of
other channel subunits, for example Kv2.1, in heteromulti-
meric channels.
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